Abstract
AbstractFollowing the results of the ENSEMBLE 2 study, which demonstrated improved vaccine efficacy of a two-dose regimen of Ad26.COV.2 vaccine given 2 months apart, we expanded the Sisonke study which had provided single dose Ad26.COV.2 vaccine to almost 500 000 health care workers (HCW) in South Africa to include a booster dose of the Ad26.COV.2. Sisonke 2 enrolled 227 310 HCW from the 8 November to the 17 December 2021. Enrolment commenced before the onset of the Omicron driven fourth wave in South Africa affording us an opportunity to evaluate early VE in preventing hospital admissions of a homologous boost of the Ad26.COV.2 vaccine given 6-9 months after the initial vaccination in HCW.We estimated vaccine effectiveness (VE) of the Ad26.COV2.S vaccine booster in 69 092 HCW as compared to unvaccinated individuals enrolled in the same managed care organization using a test negative design. We compared VE against COVID19 admission for omicron during the period 15 November to 20 December 2021. After adjusting for confounders, we observed that VE for hospitalisation increased over time since booster dose, from 63% (95%CI 31-81%); to 84% (95% CI 67-92%) and then 85% (95% CI: 54-95%), 0-13 days, 14-27 days, and 1-2 months post-boost.We provide the first evidence of the effectiveness of a homologous Ad26.COV.2 vaccine boost given 6-9 months after the initial single vaccination series during a period of omicron variant circulation. This data is important given the increased reliance on the Ad26.COV.2 vaccine in Africa.
Publisher
Cold Spring Harbor Laboratory
Reference12 articles.
1. Chotiner I. How South African Researchers Identified the Omicron Variant of COVID. The New Yorker. 2021 30 November 2021. Available from https://www.newyorker.com/news/q-and-a/how-south-african-researchers-identified-the-omicron-variant-of-covid. Accessed 17 December 2021.
2. Callaway E. Heavily mutated Omicron variant puts scientists on alert. Nature Magazine. 2021. Available from https://www.scientificamerican.com/article/heavily-mutated-omicron-variant-puts-scientists-on-alert/. Accessed 17 December 2021.
3. World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. Available from https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern. Accesed 17 December 2021.
4. Grabowski F , Kochanczyk M , Lipniacki T. Omicron strain spreads with the doubling time of 3.2—3.6 days in South Africa province of Gauteng that achieved herd immunity to Delta variant. MedRxiv 2021: doi: https://doi.org/10.1101/2021.12.08.21267494.
5. de Oliveira T , Venter M , Bhiman J , Scheepers C , Preiser W. Here’s what Omicron can tell us about how COVID-19 variants are discovered. World Economic Forum, 2021. Available from https://www.weforum.org/agenda/2021/11/coronavirus-variant-discovery-omicron-health/. Accessed 17 December 2021.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献